Kyle Eastman
Vice President, Head of Chemistry Halda Therapeutics, LLC
Seminars
Thursday 29th January 2026
RIPTACs: Harnessing Cooperative PPIs to Drive Stable Ternary Complexes & Clinical Promise
3:00 pm
- Hypothesis driven approach to achieve novel induced proximity pairings with unique mechanism-of-action
- Targeting a cooperative ternary complex to achieve exquisitely selective functional impact in oncology
- Driving translational progress through in vitro, in vivo, and toxicology studies, to emerging clinical data that highlight RIPTACs’ therapeutic promise
